235 related articles for article (PubMed ID: 14645419)
1. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
[TBL] [Abstract][Full Text] [Related]
2. The expression of MCM-2 in invasive breast carcinoma: a stereologic approach.
Cobanoglu U; Mungan S; Gundogdu C; Ersoz S; Ozoran Y; Aydin F
Bratisl Lek Listy; 2010; 111(1):45-9. PubMed ID: 20429312
[TBL] [Abstract][Full Text] [Related]
3. Correlation of intensity of MT-I/II expression with Ki-67 and MCM-2 proteins in invasive ductal breast carcinoma.
Wojnar A; Pula B; Piotrowska A; Jethon A; Kujawa K; Kobierzycki C; Rys J; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2011 Sep; 31(9):3027-33. PubMed ID: 21868554
[TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
6. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of proliferative markers ki-67 and repp86 in breast cancer.
Mohsenifar J; Almassi-Aghdam M; Mohammad-Taheri Z; Zare K; Jafari B; Atri M; Mortazavi SH; Azadeh P; Bagherzadeh M; Azargashb E; Rahimi F
Arch Iran Med; 2007 Jan; 10(1):27-31. PubMed ID: 17198450
[TBL] [Abstract][Full Text] [Related]
9. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
11. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up.
Nishimiya H; Kosaka Y; Yamashita K; Minatani N; Kikuchi M; Ema A; Nakamura K; Waraya M; Sengoku N; Tanino H; Kuranami M; Watanabe M
Anticancer Res; 2014 Jan; 34(1):259-68. PubMed ID: 24403472
[TBL] [Abstract][Full Text] [Related]
13. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H
J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
16. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
Grönberg M; Fjällskog ML; Jirström K; Janson ET
Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
[TBL] [Abstract][Full Text] [Related]
18. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
[TBL] [Abstract][Full Text] [Related]
19. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
20. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.
Gonzalez MA; Tachibana KE; Chin SF; Callagy G; Madine MA; Vowler SL; Pinder SE; Laskey RA; Coleman N
J Pathol; 2004 Oct; 204(2):121-30. PubMed ID: 15376260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]